MGMT - Overview: MGMT Promoter Methylation, Tumor

Test Catalog

Test Name

Test ID: MGMT    
MGMT Promoter Methylation, Tumor

Useful For Suggests clinical disorders or settings where the test may be helpful

Prognostication of newly diagnosed glioblastomas

 

Identifying newly diagnosed glioblastomas that may respond to alkylating chemotherapy (ie, temozolomide)

 

Guiding therapy decision making for newly diagnosed glioblastomas in elderly patients (>60 years)

Highlights

MGMT promoter methylation status has prognostic and predictive value for glioblastoma patients

Additional Tests Lists tests that are always performed, at an additional charge, with the initial tests

Test IDReporting NameAvailable SeparatelyAlways Performed
SLIRVSlide Review in MGNo, (Bill Only)Yes

Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

When this test is ordered, slide review will always be performed at an additional charge.

Method Name A short description of the method used to perform the test

Methylation-Specific Polymerase Chain Reaction (PCR) Analysis

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name A shorter or abbreviated version of the Published Name for a test; an abbreviated test name

MGMT Promoter Methylation, Tumor